Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Abraxane
Active Ingredient: Paclitaxel 100mg
Dosage Form: Powder for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Abraxis BioScience LLC, Arizona, United States of America
Fresenius Kabi USA LLC, Illinois, United States of America
Fresenius Kabi USA LLC, New York, United States of America
Product: Ferinject
Active Ingredient: Ferric carboxymaltose 180mg equivalent to iron 50mg
Dosage Form: Solution for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: BIPSO GmbH, Singen Baden, Germany
Dated this 17th day of May 2013.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).